Case Study: Biotech Company
Biotech CEO Takes on Wall Street Skeptics

Communicating with Confidence to Wall Street

Russo Partners built an investor relations program from the ground up shortly after a new management team took over the helm at the company.

The investor relations effort focused on putting in place a proactive program of outreach to the financial community by identifying appropriate members of the financial community, the right conferences for participation and working with banks to schedule non-deal roadshows in the US, Asia and Europe.

The firm also worked with the client to prepare management for tough questions from Wall Street.

We initiated discussions to key financial analysts to explain how the company was successfully commercializing its newly FDA-approved drug, while expanding the labeling and advancing other drugs through its pipeline. As management clearly and confidently articulated its new messages and strategy, Wall Street gained a better understanding of the company and new investors came on board.